Skip to main content
Clinical Trials/ACTRN12621001143819
ACTRN12621001143819
Not yet recruiting
Phase 2

A multi-centre, randomised trial of periprostatic nerve block in transperineal prostate biopsy under general anaesthesia in patients with suspected prostate cancer.

Chris O Brien Lifehouse0 sites50 target enrollmentAugust 25, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
prostate cancer
Sponsor
Chris O Brien Lifehouse
Enrollment
50
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 25, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients undergoing transperineal prostate biopsy.
  • 2\.Patients who can provide informed consent for participation in this study.

Exclusion Criteria

  • 1\.Any patient who cannot provide informed consent or is unwilling to participate in this study.
  • 2\.Any patient who has received a locoregional nerve block in the 24 hours prior to transperineal nerve block.
  • 3\.Any patient with a history of anaphylaxis following local anaesthetic injection.
  • 4\.Any patient unable to communicate, read or write in English to a level where they are able to understand the study and consent to inclusion.

Outcomes

Primary Outcomes

Not specified

Similar Trials